Search Results - "Ostrosky Zeichner, L."

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent? by Espinel-Ingroff, A, Arendrup, M C, Pfaller, M A, Bonfietti, L X, Bustamante, B, Canton, E, Chryssanthou, E, Cuenca-Estrella, M, Dannaoui, E, Fothergill, A, Fuller, J, Gaustad, P, Gonzalez, G M, Guarro, J, Lass-Flörl, C, Lockhart, S R, Meis, J F, Moore, C B, Ostrosky-Zeichner, L, Pelaez, T, Pukinskas, S R B S, St-Germain, G, Szeszs, M W, Turnidge, J

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole by Espinel-Ingroff, A, Aller, A I, Canton, E, Castañón-Olivares, L R, Chowdhary, A, Cordoba, S, Cuenca-Estrella, M, Fothergill, A, Fuller, J, Govender, N, Hagen, F, Illnait-Zaragozi, M T, Johnson, E, Kidd, S, Lass-Flörl, C, Lockhart, S R, Martins, M A, Meis, J F, Melhem, M S C, Ostrosky-Zeichner, L, Pelaez, T, Pfaller, M A, Schell, W A, St-Germain, G, Trilles, L, Turnidge, J

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole by ESPINEL-INGROFF, A, PFALLER, M. A, MEIS, J. F, MELHEM, M. S. C, OSTROSKY-ZEICHNER, L, PELAEZ, T, SZESZS, M. W, ST-GERMAIN, G, BONFIETTI, L. X, GUARRO, J, TURNIDGE, J, BUSTAMANTE, B, CANTON, E, FOTHERGILL, A, FULLER, J, GONZALEZ, G. M, LASS-FLÖRL, C, LOCKHART, S. R, MARTIN-MAZUELOS, E

“…Although epidemiological cutoff values (ECVs) have been established for Candida spp. and the triazoles, they are based on MIC data from a single laboratory. We…”
Get full text

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine by ESPINEL-LNGROFF, A, CHOWDHARY, A, LOCKHART, S. R, MARTINS, M. A, MEIS, J. F, MELHEM, M. S. C, OSTROSKY-ZEICHNER, L, PELAEZ, T, PFALLER, M. A, SCHELL, W. A, TRILLES, L, KIDD, S, CUENCA-ESTRELLA, M, TURNIDGE, J, FOTHERGILL, A, FULLER, J, HAGEN, F, GOVENDER, N, GUARRO, J, JOHNSON, E, LASS-FLÖRL, C

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints by Pfaller, M.A, Diekema, D.J, Ostrosky-Zeichner, L, Rex, J.H, Alexander, B.D, Andes, D, Brown, S.D, Chaturvedi, V, Ghannoum, M.A, Knapp, C.C, Sheehan, D.J, Walsh, T.J

“…The CLSI Antifungal Subcommittee followed the M23-A2 "blueprint" to develop interpretive MIC breakpoints for anidulafungin, caspofungin, and micafungin against…”
Get full text

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution by PFALLER, M. A, ESPINEL-INGROFF, A, LOCKHART, S. R, MARTIN-MAZUELOS, E, MELHEM, M. S. C, OSTROSKY-ZEICHNER, L, PAPPAS, P, PELAEZ, T, PEMAN, J, REX, J, SZESZS, M. W, CANTON, E, CASTANHEIRA, M, CUENCA-ESTRELLA, M, DIEKEMA, D. J, FOTHERGILL, A, FULLER, J, GHANNOUM, M, JONES, R. N

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Combination antifungal therapy: a critical review of the evidence by Ostrosky-Zeichner, L.

“…Invasive fungal infections have extremely high rates of morbidity and mortality, particularly in immunocompromised hosts. Combination antifungal therapy is…”
Get full text

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting by OSTROSKY-ZEICHNER, L, SABLE, C, NUCCI, M, PAPPAS, P. G, BRADLEY, M. E, MAJOR, S, ZIMMER, L, WALLACE, D, DISMUKES, W. E, REX, J. H, SOBEL, J, ALEXANDER, B. D, DONOWITZ, G, KAN, V, KAUFFMAN, C. A, KETT, D, LARSEN, R. A, MORRISON, V

“…The study presented here was performed in order to create a rule that identifies subjects at high risk for invasive candidiasis in the intensive care setting…”
Get full text

Amphotericin B: Time for a New “Gold Standard” by Saravolatz, Louis D., Ostrosky-Zeichner, Luis, Marr, Kieren A., Rex, John H., Cohen, Stuart H.

“…When introduced in 1959, amphotericin B deoxycholate (AmBD) was clearly a life-saving drug. Randomized studies demonstrating its efficacy were not thought to…”
Get full text

Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods by PFALLER, M. A, DIEKEMA, D. J, JOHNSON, E. M, KNAPP, C. C, MOTYL, M. R, OSTROSKY-ZEICHNER, L, SHEEHAN, D. J, WASH, T, GHANNOUM, M. A, REX, J. H, ALEXANDER, B. D, ANDES, D, BROWN, S. D, CHATURVEDI, V, ESPINEL-LNGROFF, A, FOWLER, C. L

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method by Pfaller, M A, Espinel-Ingroff, A, Bustamante, B, Canton, E, Diekema, D J, Fothergill, A, Fuller, J, Gonzalez, G M, Guarro, J, Lass-Flörl, C, Lockhart, S R, Martin-Mazuelos, E, Meis, J F, Ostrosky-Zeichner, L, Pelaez, T, St-Germain, G, Turnidge, J

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity by McAndrews, Kathleen M, Dowlatshahi, Dara P, Dai, Jianli, Becker, Lisa M, Hensel, Janine, Snowden, Laura M, Leveille, Jennifer M, Brunner, Michael R, Holden, Kylie W, Hopkins, Nikolas S, Harris, Alexandria M, Kumpati, Jerusha, Whitt, Michael A, Lee, J Jack, Ostrosky-Zeichner, Luis L, Papanna, Ramesha, LeBleu, Valerie S, Allison, James P, Kalluri, Raghu

“…Evaluation of potential immunity against the novel severe acute respiratory syndrome (SARS) coronavirus that emerged in 2019 (SARS-CoV-2) is essential for…”
Get full text

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia by OSTROSKY-ZEICHNER, L, KONTOYIANNIS, D, LAU, W, FACKLAM, D, BUELL, D. N, RAFFALLI, J, MULLANE, K. M, VAZQUEZ, J, ANAISSIE, E. J, LIPTON, J, JACOBS, P, VAN RENSBURG, J. H, REX, J. H

“…Candida spp. are the fourth leading cause of bloodstream infections, and non-albicans species are increasing in importance. Micafungin is a new echinocandin…”
Get full text

Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials by Horn, D. L, Ostrosky-Zeichner, L, Morris, M. I, Ullmann, A. J, Wu, C, Buell, D. N, Kovanda, L. L, Cornely, O. A

“…Crude and attributable mortality rates in patients with candidemia and invasive candidiasis remain unacceptably high. It is important to reach a more complete…”
Get full text

Quality Control Guidelines for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Disk Diffusion Susceptibility Tests with Nonsupplemented Mueller-Hinton Agar (CLSI M51-A Document) for Nondermatophyte Filamentous Fungi by ESPINEL-INGROFF, A, CANTON, E, TURNIDGE, J, FOTHERGILL, A, GHANNOUM, M, JOHNSON, E, JONES, R. N, OSTROSKY-ZEICHNER, L, SCHELL, W, GIBBS, D. L, WANG, A

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Quality Control and Reference Guidelines for CLSI Broth Microdilution Susceptibility Method (M38-A Document) for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole by Espinel-Ingroff, A, Fothergill, A, Ghannoum, M, Manavathu, E, Ostrosky-Zeichner, L, Pfaller, M, Rinaldi, M, Schell, W, Walsh, T

“…Although standard conditions are available for testing the susceptibilities of filamentous fungi to antifungal agents by the Clinical and Laboratory Standards…”
Get full text

A pseudo-outbreak of disseminated cryptococcal disease after orthotopic heart transplantation by Kennedy, E., Vanichanan, J., Rajapreyar, I., Gonzalez, B., Nathan, S., Gregoric, I., Kar, B., Loyalka, P., Weeks, P., Chavez, V., Wanger, A., Ostrosky Zeichner, L.

“…Summary Cryptococcal infection is the third most common invasive fungal infection (IFI) among solid‐organ transplant (SOT) recipients and is considered an…”
Get full text

Voriconazole salvage treatment of invasive candidiasis by OSTROSKY-ZEICHNER, L, OUDE LASHOF, A. M. L, KULLBERG, B. J, REX, J. H

“…Data on the salvage treatment of invasive candidiasis with voriconazole in 52 patients intolerant of other antifungal agents or with infection refractory to…”
Get full text

Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults by Lamoth, F, Akan, H, Andes, D, Cruciani, M, Marchetti, O, Ostrosky-Zeichner, L, Racil, Z, Clancy, C J

“…Abstract Detection of 1,3-β-d-glucan (BDG) in serum has been evaluated for its inclusion as a mycological criterion of invasive fungal infections (IFI)…”
Get full text

Quality Control and Reference Guidelines for CLSI Broth Microdilution Method (M38-A Document) for Susceptibility Testing of Anidulafungin against Molds by Espinel-Ingroff, A, Fothergill, A, Ghannoum, M, Manavathu, E, Ostrosky-Zeichner, L, Pfaller, M.A, Rinaldi, M.G, Schell, W, Walsh, T.J

“…The CLSI (formerly NCCLS) M38-A document for antifungal susceptibility testing of filamentous fungi does not describe guidelines for echinocandins. A…”
Get full text